Topic 372: development and validation of canine scfvs for pre-clinical development of targeted therapeutics - moonshot

Ended Definitive Contract Awarded Last action

Contract number
75N91018C00042
Awardee
Awarding agency
Obligated
$354,859

Award facts

Contract value 100% obligated
$354,859.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 3 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Philadelphia, PA 19146, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Change Order P00002 $0
Supplemental Agreement for work within scope P00001 $54,994
Original award $299,865

About this award

The National Cancer Institute awarded a $354,859 definitive contract to Vetigenics LLC on September 12, 2018, under a total small business set-aside, for development and validation of canine single-chain fragment variables (scFvs) for pre-clinical development of targeted therapeutics as part of the Moonshot initiative.

Place of performance is Philadelphia, PA. The contract carries a firm fixed price and ultimate completion date of September 16, 2019.

Quick answers

Who was awarded contract 75N91018C00042?

75N91018C00042 was awarded to Vetigenics LLC by National Cancer Institute (National Institutes of Health) on September 12, 2018.

How much is contract 75N91018C00042 worth?

The government has obligated $354,859 on 75N91018C00042.

Was contract 75N91018C00042 competed?

The extent of competition for 75N91018C00042 was full and open competition after exclusion of sources. The government received 3 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award